103 related articles for article (PubMed ID: 20638210)
1. Optimizing dose and administration regimen of a high-relaxivity contrast agent for myocardial MRI late gadolinium enhancement.
Secchi F; Di Leo G; Papini GD; Giacomazzi F; Di Donato M; Sardanelli F
Eur J Radiol; 2011 Oct; 80(1):96-102. PubMed ID: 20638210
[TBL] [Abstract][Full Text] [Related]
2. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
3. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine.
Durmus T; Schilling R; Doeblin P; Huppertz A; Hamm B; Taupitz M; Wagner M
Invest Radiol; 2012 Mar; 47(3):183-8. PubMed ID: 22183078
[TBL] [Abstract][Full Text] [Related]
4. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
[TBL] [Abstract][Full Text] [Related]
5. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
[TBL] [Abstract][Full Text] [Related]
6. Phase-sensitive inversion-recovery MR imaging in the detection of myocardial infarction.
Huber AM; Schoenberg SO; Hayes C; Spannagl B; Engelmann MG; Franz WM; Reiser MF
Radiology; 2005 Dec; 237(3):854-60. PubMed ID: 16304107
[TBL] [Abstract][Full Text] [Related]
7. Myocardial infarct: depiction with contrast-enhanced MR imaging--comparison of gadopentetate and gadobenate.
Schlosser T; Hunold P; Herborn CU; Lehmkuhl H; Lind A; Massing S; Barkhausen J
Radiology; 2005 Sep; 236(3):1041-6. PubMed ID: 16055693
[TBL] [Abstract][Full Text] [Related]
8. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
[TBL] [Abstract][Full Text] [Related]
9. Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T.
Wildgruber M; Stadlbauer T; Rasper M; Hapfelmeier A; Zelger O; Eckstein HH; Halle M; Rummeny EJ; Huber AM
Invest Radiol; 2014 Nov; 49(11):728-34. PubMed ID: 24872002
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
Cheong BY; Duran C; Preventza OA; Muthupillai R
AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
[TBL] [Abstract][Full Text] [Related]
11. Single-shot inversion recovery TrueFISP for assessment of myocardial infarction.
Huber A; Schoenberg SO; Spannagl B; Rieber J; Erhard I; Klauss V; Reiser MF
AJR Am J Roentgenol; 2006 Mar; 186(3):627-33. PubMed ID: 16498088
[TBL] [Abstract][Full Text] [Related]
12. Ultra low-dose of gadobenate dimeglumine for late gadolinium enhancement (LGE) imaging in acute myocardial infarction: a feasibility study.
Galea N; Francone M; Zaccagna F; Ciolina F; Cannata D; Algeri E; Agati L; Catalano C; Carbone I
Eur J Radiol; 2014 Dec; 83(12):2151-2158. PubMed ID: 25293818
[TBL] [Abstract][Full Text] [Related]
13. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla.
Klumpp B; Fenchel M; Hoevelborn T; Helber U; Scheule A; Claussen C; Miller S
Invest Radiol; 2006 Sep; 41(9):661-7. PubMed ID: 16896300
[TBL] [Abstract][Full Text] [Related]
14. Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: cardiac MR imaging study.
Nijveldt R; Hofman MB; Hirsch A; Beek AM; Umans VA; Algra PR; Piek JJ; van Rossum AC
Radiology; 2009 Feb; 250(2):363-70. PubMed ID: 19164698
[TBL] [Abstract][Full Text] [Related]
15. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience.
Krautmacher C; Willinek WA; Tschampa HJ; Born M; Träber F; Gieseke J; Textor HJ; Schild HH; Kuhl CK
Radiology; 2005 Dec; 237(3):1014-9. PubMed ID: 16237142
[TBL] [Abstract][Full Text] [Related]
16. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.
Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T
Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640
[TBL] [Abstract][Full Text] [Related]
17. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
[TBL] [Abstract][Full Text] [Related]
18. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging.
Gupta A; Lee VS; Chung YC; Babb JS; Simonetti OP
Radiology; 2004 Dec; 233(3):921-6. PubMed ID: 15516607
[TBL] [Abstract][Full Text] [Related]
19. Papillary muscle involvement in myocardial infarction: initial results using multicontrast late-enhancement MRI.
Yang Y; Connelly K; Graham JJ; Detsky J; Lee T; Walcarius R; Paul G; Wright GA; Dick AJ
J Magn Reson Imaging; 2011 Jan; 33(1):211-6. PubMed ID: 21182141
[TBL] [Abstract][Full Text] [Related]
20. First-pass myocardial perfusion cardiovascular magnetic resonance at 3 Tesla.
Su MY; Yang KC; Wu CC; Wu YW; Yu HY; Tseng RY; Tseng WY
J Cardiovasc Magn Reson; 2007; 9(4):633-44. PubMed ID: 17578718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]